• Users Online: 318
  • Print this page
  • Email this page
Year : 2014  |  Volume : 8  |  Issue : 5  |  Page : 29-32

HCV infection during renal replacement therapy: What we have learnt in two decade?

Professor & Head, Department of Nephrology, AIIMS, New Delhi 110029, India

Correspondence Address:
S K Agarwal
Professor & Head, Department of Nephrology, AIIMS, New Delhi 110029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.1016/j.ijt.2014.01.003

Get Permissions

HCV infection is most common hepatotropic blood borne infection in hemodialysis unit and prevalent differently in different units. It causes not only mortality but significant morbidity and difficulty in management of such cases. Prevention is better than treatment of such cases. In addition to following universal precaution, there is role of isolation of these patients to restrict spread of infection. If patient can afford, these patients should be treated with interferon (preferably pegylated) with/without ribavirin, whether patient is for renal transplant or not. Treatment prevent complication during maintenance hemodialysis and also following renal transplantation.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded19    
    Comments [Add]    

Recommend this journal